Condition: Rectal Cancer Recurrent · Sponsor: National Cancer Center Hospital East
JCOG1801 is a randomized phase III trial which was initiated in Japan in August 2019 to confirm the superiority of preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy for local relapse-free survival over standard treatment, i.e. surgery plus adjuvant chemotherapy, for previously non-irradiated locally recurrent rectal cancer.
This description comes directly from the study's public registry record.
Yuichiro Tsukada, MD,PhD · +80-4-7133-1111 · yutsukad@east.ncc.go.jp
Masaaki Ito, MD, PhD · +80-4-7133-1111 · maito@east.ncc.go.jp
Always discuss trial participation with your own doctor first.
| Chiba Cancer Center | Chiba, Japan | Recruiting |
| Gifu University School of Medicine | Gifu, Japan | Recruiting |
| Saitama Medical University International Medical Center | Hidaka, Japan | Not Yet Recruiting |
| Kansai Medical University Hospital | Hirakata, Japan | Not Yet Recruiting |
| Hiroshima City Asa Citizens Hospital | Hiroshima, Japan | Recruiting |
| Hiroshima City Hospital | Hiroshima, Japan | Recruiting |
| Shimane University Faculty of Medicine | Izumo, Japan | Recruiting |
| Ishikawa Prefectural Central Hospital | Kanazawa, Japan | Recruiting |
| National Cancer Center Hospital East | Kashiwa, Japan | Recruiting |
| Saitama Medical Center, Saitama Medical University | Kawagoe, Japan | Recruiting |
| Kochi Health Sciences Center | Kochi, Japan | Recruiting |
| Kumamoto University Hospital | Kumamoto, Japan | Recruiting |
+ 33 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04288999